Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Cannabis Central: All But Two NPSI Constituents Declined On Friday
10:26pm, Saturday, 02'nd May 2020
The index tracking the 35 cannabis stocks that trade for US$1/share or more (i.e. 12% of the universe of 298 companies) was down 3.9% on Friday.
Amarin (AMRN) Receives a Hold from Oppenheimer
11:18am, Friday, 01'st May 2020
Oppenheimer analyst Leland Gershell maintained a Hold rating on Amarin (AMRN) today. The company's shares closed last Thursday at $7.61, close to its
Amarin (AMRN) Receives a Hold from Oppenheimer
11:18am, Friday, 01'st May 2020
Oppenheimer analyst Leland Gershell maintained a Hold rating on Amarin (AMRN – Research Report) today. The company’s shares closed last
Viela Bio Announces Election of Rachelle Jacques to its Board of Directors
08:15pm, Thursday, 30'th Apr 2020
GAITHERSBURG, Md., April 30, 2020 -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today.
Oppenheimer Releases a Hold Rating on BioMarin Pharmaceutical (BMRN)
11:27am, Thursday, 30'th Apr 2020
In a report released today, Leland Gershell from Oppenheimer assigned a Hold rating to BioMarin Pharmaceutical (BMRN), with a price target of $88.00. The
Oppenheimer Releases a Hold Rating on BioMarin Pharmaceutical (BMRN)
11:27am, Thursday, 30'th Apr 2020
In a report released today,
Leland Gershell
from Oppenheimer assigned a
Hold
rating to BioMarin Pharmaceutical (
BMRN
–
Research Report
), with a price target of
$88.00
. The company’s shares clos
One Thing To Remember About The Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Share Price
11:20am, Thursday, 30'th Apr 2020
If you're interested in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), then you might want to consider its beta...
These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable safety profile in.
These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an...
Head-To-Head Comparison: Syndax Pharmaceuticals (NASDAQ:SNDX) vs. Corbus Pharmaceuticals (NASDAQ:CRBP)
05:44am, Wednesday, 29'th Apr 2020
Syndax Pharmaceuticals (NASDAQ:SNDX) and Corbus Pharmaceuticals (NASDAQ:CRBP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the s
Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Shareholders Booked A 86% Gain In The Last Five Years
11:05am, Tuesday, 28'th Apr 2020
When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking...
Geode Capital Management LLC Has $4.26 Million Stock Holdings in Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
10:00am, Tuesday, 28'th Apr 2020
Geode Capital Management LLC increased its holdings in shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) by 4.5% in the 4th quarter, according to its most recent filing with the SEC. The fun
Oppenheimer Maintains Their Buy Rating on Vaccinex (VCNX)
02:21am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Vaccinex (VCNX) yesterday and set a price target of $22.00. The company's shares closed
Oppenheimer Maintains Their Buy Rating on Vaccinex (VCNX)
02:21am, Tuesday, 28'th Apr 2020
Oppenheimer analyst
Leland Gershell
maintained a
Buy
rating on Vaccinex (
VCNX
–
Research Report
) yesterday and set a price target of
$22.00
. The company’s shares closed last Monday at $4.17, cl
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Receives Average Recommendation of "Buy" from Analysts
06:34am, Sunday, 26'th Apr 2020
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated
